Anti-IgE [EPC]

Anti-IgE [EPC] was reported 87093 times

These side effects are most commonly reported by patients taking drugs of the Anti-IgE [EPC] class:

# Drug class Count
0 ASTHMA 12371
1 URTICARIA 11750
2 NO ADVERSE EVENT 11200
3 OFF LABEL USE 11100
4 DYSPNOEA 10558
5 DRUG INEFFECTIVE 8627
6 COUGH 7198
7 PRURITUS 6583
8 FATIGUE 6267
9 MALAISE 5801
10 WHEEZING 5683
11 HEADACHE 5583
12 PNEUMONIA 5473
13 PAIN 4574
14 ANAPHYLACTIC REACTION 4554
15 NASOPHARYNGITIS 4043
16 ARTHRALGIA 3894
17 HYPERSENSITIVITY 3613
18 WEIGHT DECREASED 3578
19 DIZZINESS 3555
20 RASH 3473
21 PYREXIA 3320
22 NAUSEA 3232
23 DRUG HYPERSENSITIVITY 3173
24 PRODUCT DOSE OMISSION ISSUE 3100
25 BLOOD PRESSURE INCREASED 3064
26 VOMITING 3033
27 CHEST DISCOMFORT 2947
28 INFLUENZA 2834
29 WEIGHT INCREASED 2785
30 PRODUCTIVE COUGH 2613
31 ERYTHEMA 2449
32 ANGIOEDEMA 2312
33 PAIN IN EXTREMITY 2297
34 SINUSITIS 2291
35 HEART RATE INCREASED 2286
36 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2255
37 NASAL CONGESTION 2225
38 CHEST PAIN 2179
39 OROPHARYNGEAL PAIN 2166
40 BRONCHITIS 2139
41 ASTHENIA 2131
42 ANXIETY 2088
43 INSOMNIA 2068
44 DIARRHOEA 2010
45 ILLNESS 1952
46 OBSTRUCTIVE AIRWAYS DISORDER 1882
47 FALL 1776
48 INJECTION SITE PAIN 1769
49 MYALGIA 1765
50 PERIPHERAL SWELLING 1742
51 RHINORRHOEA 1736
52 FEELING ABNORMAL 1730
53 SPUTUM DISCOLOURED 1657
54 SWELLING 1652
55 FORCED EXPIRATORY VOLUME DECREASED 1628
56 BACK PAIN 1612
57 BLOOD PRESSURE SYSTOLIC INCREASED 1607
58 CONDITION AGGRAVATED 1584
59 OEDEMA 1571
60 ALOPECIA 1561
61 HYPERTENSION 1559
62 DEATH 1523
63 STRESS 1511
64 LOWER RESPIRATORY TRACT INFECTION 1418
65 COVID-19 1405
66 MIGRAINE 1332
67 SWELLING FACE 1316
68 MIDDLE INSOMNIA 1275
69 ABDOMINAL PAIN 1263
70 PARAESTHESIA 1263
71 INCORRECT DOSE ADMINISTERED 1262
72 RESPIRATORY TRACT INFECTION 1254
73 GAIT DISTURBANCE 1160
74 PRODUCT USE IN UNAPPROVED INDICATION 1146
75 DYSPNOEA EXERTIONAL 1131
76 CONTUSION 1066
77 HYPOAESTHESIA 1010
78 ABDOMINAL PAIN UPPER 1003
79 DYSPHONIA 994
80 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 993
81 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 987
82 CHILLS 981
83 SOMNOLENCE 981
84 INFECTION 977
85 URINARY TRACT INFECTION 957
86 INFLUENZA LIKE ILLNESS 949
87 OEDEMA PERIPHERAL 940
88 BODY TEMPERATURE DECREASED 914
89 GASTROOESOPHAGEAL REFLUX DISEASE 914
90 LUNG DISORDER 910
91 LIP SWELLING 903
92 DEPRESSION 896
93 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 884
94 INTENTIONAL PRODUCT USE ISSUE 879
95 THROAT IRRITATION 841
96 MUSCLE SPASMS 837
97 MATERNAL EXPOSURE DURING PREGNANCY 836
98 BLOOD PRESSURE DECREASED 835
99 THROAT TIGHTNESS 831
100 RESPIRATORY TRACT CONGESTION 828
101 BLOOD IMMUNOGLOBULIN E INCREASED 827
102 DISCOMFORT 822
103 UPPER RESPIRATORY TRACT INFECTION 804
104 RESPIRATORY DISORDER 795
105 SENSITIVITY TO WEATHER CHANGE 792
106 TREMOR 789
107 ASTHMATIC CRISIS 778
108 SNEEZING 768
109 BURNING SENSATION 759
110 FEELING HOT 745
111 GENERAL PHYSICAL HEALTH DETERIORATION 744
112 CHRONIC SPONTANEOUS URTICARIA 742
113 HYPERHIDROSIS 740
114 FLUSHING 725
115 DECREASED APPETITE 724
116 OXYGEN SATURATION DECREASED 723
117 VIRAL INFECTION 722
118 ECZEMA 719
119 ACCIDENTAL EXPOSURE TO PRODUCT 718
120 SLEEP DISORDER 707
121 PALPITATIONS 703
122 SYNCOPE 696
123 SEASONAL ALLERGY 691
124 EYE SWELLING 686
125 ANAPHYLACTIC SHOCK 674
126 FULL BLOOD COUNT ABNORMAL 673
127 DEVICE DEFECTIVE 668
128 JOINT SWELLING 667
129 HYPOTENSION 653
130 DIABETES MELLITUS 652
131 SKIN PLAQUE 652
132 ABDOMINAL DISCOMFORT 651
133 NASAL POLYPS 649
134 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 645
135 RESPIRATORY RATE INCREASED 644
136 EYE PRURITUS 632
137 LOSS OF CONSCIOUSNESS 627
138 HERPES ZOSTER 623
139 NEEDLE ISSUE 620
140 INJECTION SITE ERYTHEMA 618
141 SWOLLEN TONGUE 616
142 TACHYCARDIA 609
143 PRODUCT STORAGE ERROR 604
144 IDIOPATHIC URTICARIA 603
145 ILL-DEFINED DISORDER 602
146 UPPER-AIRWAY COUGH SYNDROME 597
147 ABDOMINAL DISTENSION 584
148 THERAPEUTIC RESPONSE DECREASED 584
149 ARTHRITIS 581
150 MEMORY IMPAIRMENT 579
151 MOBILITY DECREASED 579
152 SECRETION DISCHARGE 578
153 MUSCULAR WEAKNESS 574
154 BREATH SOUNDS ABNORMAL 566
155 DEVICE ISSUE 563
156 SINUS CONGESTION 563
157 RALES 551
158 GASTROINTESTINAL DISORDER 550
159 MUSCULOSKELETAL STIFFNESS 548
160 DYSPHAGIA 545
161 CEREBROVASCULAR ACCIDENT 537
162 VISION BLURRED 534
163 BRONCHOSPASM 532
164 LACRIMATION INCREASED 526
165 INJECTION SITE SWELLING 525
166 FOOD ALLERGY 524
167 DRY SKIN 522
168 INJECTION SITE REACTION 512
169 MYOCARDIAL INFARCTION 512
170 EAR INFECTION 507
171 INFLAMMATION 507
172 EAR PAIN 506
173 PHARYNGEAL SWELLING 506
174 RHINITIS ALLERGIC 491
175 INJECTION SITE BRUISING 490
176 BRONCHIECTASIS 485
177 PRODUCT USE ISSUE 482
178 HYPOVENTILATION 467
179 BLISTER 459
180 PRODUCT QUALITY ISSUE 458
181 CELLULITIS 455
182 BONE PAIN 452
183 DYSPEPSIA 448
184 UNDERDOSE 448
185 ANAEMIA 446
186 INJECTION SITE PRURITUS 446
187 VISUAL IMPAIRMENT 442
188 LUNG INFECTION 433
189 SCRATCH 433
190 NERVOUSNESS 432
191 PULMONARY EMBOLISM 427
192 RASH ERYTHEMATOUS 426
193 SPEECH DISORDER 424
194 CARDIAC DISORDER 420
195 NECK PAIN 420
196 CONSTIPATION 417
197 VERTIGO 407
198 HOT FLUSH 403
199 DRUG INTOLERANCE 402
200 HAEMORRHAGE 402
201 NASAL OEDEMA 402
202 SKIN LESION 402
203 BLOOD GLUCOSE INCREASED 401
204 PRODUCT COMPLAINT 394
205 BREAST CANCER 393
206 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 392
207 MUSCULOSKELETAL PAIN 392
208 PREGNANCY 390
209 EOSINOPHILIA 385
210 RASH PRURITIC 385
211 PULMONARY CONGESTION 383
212 EOSINOPHIL COUNT INCREASED 382
213 APHONIA 378
214 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 373
215 MAST CELL ACTIVATION SYNDROME 372
216 PULMONARY MASS 369
217 BODY TEMPERATURE INCREASED 367
218 THROMBOSIS 366
219 SINUS DISORDER 365
220 LYMPHADENOPATHY 360
221 RHINITIS 360
222 HEART RATE DECREASED 357
223 TYPE 2 DIABETES MELLITUS 357
224 ROAD TRAFFIC ACCIDENT 356
225 SKIN BURNING SENSATION 355
226 TEMPERATURE INTOLERANCE 354
227 LIMB INJURY 352
228 BALANCE DISORDER 351
229 NEPHROLITHIASIS 349
230 INTENTIONAL PRODUCT MISUSE 347
231 SKIN DISCOLOURATION 341
232 THERAPEUTIC RESPONSE SHORTENED 340
233 ACNE 337
234 ABORTION SPONTANEOUS 334
235 CHOKING 334
236 PARAESTHESIA ORAL 332
237 SEPSIS 330
238 SEIZURE 329
239 CATARACT 327
240 EPISTAXIS 326
241 TREATMENT FAILURE 324
242 BLOOD POTASSIUM DECREASED 323
243 DEVICE MALFUNCTION 322
244 MULTIPLE ALLERGIES 322
245 HAEMOGLOBIN DECREASED 319
246 PULMONARY FUNCTION TEST DECREASED 319
247 CONFUSIONAL STATE 318
248 HAEMOPTYSIS 316
249 DRY MOUTH 315
250 RESPIRATORY DISTRESS 308
251 SLEEP APNOEA SYNDROME 306
252 BLOOD COUNT ABNORMAL 304
253 PULMONARY FUNCTION TEST ABNORMAL 304
254 MENTAL DISORDER 302
255 LIMB DISCOMFORT 298
256 MOVEMENT DISORDER 297
257 RHEUMATOID ARTHRITIS 297
258 THERAPEUTIC PRODUCT EFFECT DECREASED 296
259 SYRINGE ISSUE 295
260 OSTEOARTHRITIS 294
261 THERAPY NON-RESPONDER 293
262 CARDIAC FAILURE 291
263 FIBROMYALGIA 291
264 PRODUCT AVAILABILITY ISSUE 291
265 DEPRESSED MOOD 284
266 INTERCEPTED PRODUCT STORAGE ERROR 283
267 HYPOACUSIS 281
268 HYPOXIA 281
269 WHITE BLOOD CELL COUNT INCREASED 281
270 FEELING COLD 278
271 VASCULITIS 277
272 BLOOD CHOLESTEROL INCREASED 274
273 EAR PRURITUS 268
274 ATRIAL FIBRILLATION 266
275 PERFUME SENSITIVITY 266
276 INJECTION SITE HAEMORRHAGE 265
277 POOR QUALITY SLEEP 265
278 GASTROENTERITIS VIRAL 260
279 OCULAR HYPERAEMIA 259
280 QUALITY OF LIFE DECREASED 259
281 LIGAMENT SPRAIN 257
282 TINNITUS 257
283 AGITATION 256
284 PSORIASIS 254
285 WOUND 254
286 EXPOSURE VIA SKIN CONTACT 252
287 GAIT INABILITY 252
288 SKIN EXFOLIATION 250
289 PHARYNGITIS 249
290 PHARYNGEAL OEDEMA 248
291 AMNESIA 247
292 PANIC ATTACK 247
293 THROAT CLEARING 246
294 LOWER RESPIRATORY TRACT CONGESTION 245
295 JOINT INJURY 244
296 PLATELET COUNT INCREASED 242
297 HOSPITALISATION 241
298 THERAPY PARTIAL RESPONDER 241
299 OSTEOPOROSIS 238
300 DRUG DEPENDENCE 237
301 RASH MACULAR 237
302 CYSTITIS 236
303 EXPOSURE DURING PREGNANCY 236
304 PRODUCT PRESCRIBING ERROR 236
305 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 234
306 ARRHYTHMIA 233
307 FRUSTRATION TOLERANCE DECREASED 233
308 DRY EYE 231
309 RIB FRACTURE 230
310 UPPER LIMB FRACTURE 228
311 NASAL DISCHARGE DISCOLOURATION 226
312 SKIN DISORDER 225
313 DIVERTICULITIS 224
314 FEAR 224
315 LETHARGY 222
316 TOTAL LUNG CAPACITY DECREASED 221
317 DISEASE RECURRENCE 220
318 PLEURAL EFFUSION 220
319 PROCEDURAL PAIN 220
320 DERMATITIS ATOPIC 219
321 PAPULE 219
322 INJURY 218
323 BLOOD IRON DECREASED 216
324 NEOPLASM MALIGNANT 216
325 CRYING 214
326 INJECTION SITE URTICARIA 214
327 DEHYDRATION 213
328 HEREDITARY ANGIOEDEMA 212
329 BLOOD LACTIC ACID INCREASED 211
330 ALLERGY TO ANIMAL 210
331 DEEP VEIN THROMBOSIS 210
332 LUNG NEOPLASM MALIGNANT 210
333 CHEST X-RAY ABNORMAL 209
334 OROPHARYNGEAL DISCOMFORT 209
335 FORCED VITAL CAPACITY DECREASED 208
336 LARYNGITIS 208
337 DUST ALLERGY 207
338 RESPIRATORY FAILURE 207
339 BLOOD CREATININE INCREASED 206
340 HYPOKINESIA 206
341 TRANSIENT ISCHAEMIC ATTACK 206
342 CONCOMITANT DISEASE AGGRAVATED 205
343 FOETAL EXPOSURE DURING PREGNANCY 205
344 SINUS PAIN 205
345 UNEVALUABLE EVENT 205
346 BLOOD TEST ABNORMAL 204
347 EYE PAIN 204
348 SUICIDAL IDEATION 203
349 EAR DISCOMFORT 202
350 WRIST FRACTURE 202
351 INTERVERTEBRAL DISC PROTRUSION 201
352 STAPHYLOCOCCAL INFECTION 201
353 PRURITUS GENERALISED 199
354 OBESITY 198
355 HYPERGLYCAEMIA 196
356 PALLOR 196
357 PARANASAL SINUS DISCOMFORT 196
358 ARTHROPATHY 195
359 FUNGAL INFECTION 195
360 MOUTH SWELLING 195
361 NEUROPATHY PERIPHERAL 194
362 EMOTIONAL DISTRESS 193
363 DRUG DOSE OMISSION 192
364 MUSCULOSKELETAL CHEST PAIN 191
365 ADVERSE DRUG REACTION 190
366 HYPOAESTHESIA ORAL 190
367 PHOTOSENSITIVITY REACTION 190
368 SYMPTOM RECURRENCE 190
369 FOOT FRACTURE 189
370 SKIN LACERATION 188
371 DYSURIA 187
372 DISTURBANCE IN ATTENTION 186
373 BRONCHIAL SECRETION RETENTION 183
374 EMPHYSEMA 182
375 MASS 181
376 OVERDOSE 181
377 INTERCEPTED MEDICATION ERROR 179
378 PULMONARY FIBROSIS 179
379 IRRITABILITY 178
380 HEAD DISCOMFORT 177
381 INTENTIONAL DOSE OMISSION 177
382 PNEUMONITIS 177
383 RENAL IMPAIRMENT 177
384 BLOOD PRESSURE DIASTOLIC DECREASED 175
385 GASTROENTERITIS 175
386 FACE OEDEMA 174
387 IMMUNODEFICIENCY 173
388 HEART RATE IRREGULAR 172
389 INCREASED BRONCHIAL SECRETION 171
390 DECREASED ACTIVITY 170
391 HEPATIC ENZYME INCREASED 170
392 SKIN REACTION 170
393 POST PROCEDURAL COMPLICATION 169
394 ACCIDENT 168
395 HYPOTHYROIDISM 167
396 NEURALGIA 167
397 LOCALISED INFECTION 166
398 ASPHYXIA 165
399 DERMATITIS 165
400 DRUG EXPOSURE DURING PREGNANCY 165
401 DYSARTHRIA 165
402 EYE IRRITATION 163
403 BACTERIAL INFECTION 162
404 BLOOD PRESSURE FLUCTUATION 162
405 DYSGEUSIA 162
406 MYOPATHY 162
407 RENAL FAILURE 162
408 BRAIN FOG 161
409 SYSTEMIC LUPUS ERYTHEMATOSUS 161
410 CHRONIC SINUSITIS 160
411 POLLAKIURIA 160
412 PULMONARY OEDEMA 160
413 KIDNEY INFECTION 159
414 ORAL HERPES 159
415 CONJUNCTIVITIS 158
416 EYE DISORDER 158
417 SKIN IRRITATION 158
418 THERAPY INTERRUPTED 158
419 HAEMATOMA 157
420 VITAL CAPACITY DECREASED 157
421 BLOOD URINE PRESENT 156
422 DYSPNOEA AT REST 155
423 FLUID RETENTION 155
424 INJECTION SITE RASH 155
425 PAIN OF SKIN 155
426 SARS-COV-2 TEST POSITIVE 155
427 SERUM SICKNESS 154
428 MATERNAL EXPOSURE TIMING UNSPECIFIED 153
429 SMOKE SENSITIVITY 153
430 ADRENAL INSUFFICIENCY 152
431 CHOLELITHIASIS 152
432 CREPITATIONS 152
433 DERMATITIS CONTACT 152
434 ANGINA PECTORIS 151
435 MUSCULOSKELETAL DISCOMFORT 150
436 AUTOIMMUNE DISORDER 148
437 INJECTION SITE DISCOMFORT 148
438 BLOOD PRESSURE ABNORMAL 147
439 RESTRICTIVE PULMONARY DISEASE 147
440 HYPERVENTILATION 146
441 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 145
442 NIGHT SWEATS 145
443 HYPERSOMNIA 144
444 IMMUNE SYSTEM DISORDER 144
445 MATERNAL EXPOSURE BEFORE PREGNANCY 143
446 PRESYNCOPE 143
447 RUBBER SENSITIVITY 143
448 CARDIAC ARREST 142
449 PHARYNGITIS STREPTOCOCCAL 141
450 REVERSIBLE AIRWAYS OBSTRUCTION 141
451 C-REACTIVE PROTEIN INCREASED 140
452 DYSSTASIA 140
453 ASPIRATION 139
454 BLINDNESS 139
455 HEAD INJURY 139
456 LIVER FUNCTION TEST INCREASED 139
457 RENAL DISORDER 139
458 CARDIAC FAILURE CONGESTIVE 137
459 CLOSTRIDIUM DIFFICILE INFECTION 137
460 SKIN INFECTION 137
461 PANCREATITIS 135
462 SENSATION OF FOREIGN BODY 135
463 BLOOD CALCIUM INCREASED 134
464 GASTRITIS 134
465 TOOTH ABSCESS 134
466 HERNIA 133
467 ANOSMIA 132
468 BLOOD GLUCOSE DECREASED 132
469 HAEMATOCHEZIA 132
470 INCREASED UPPER AIRWAY SECRETION 130
471 EAR CONGESTION 129
472 ORAL CANDIDIASIS 129
473 BACK INJURY 128
474 DRUG EFFECT DECREASED 128
475 TRANSAMINASES INCREASED 128
476 LUNG OPACITY 127
477 ANAPHYLACTOID REACTION 126
478 LARYNGEAL OEDEMA 126
479 CONCUSSION 124
480 HUMIDITY INTOLERANCE 124
481 TENDONITIS 124
482 DRY THROAT 122
483 EXERCISE TOLERANCE DECREASED 122
484 MUSCLE TIGHTNESS 122
485 RHONCHI 122
486 JOINT STIFFNESS 121
487 THYROID DISORDER 121
488 TOOTH INFECTION 121
489 COLD SWEAT 120
490 DRUG INTERACTION 120
491 GLAUCOMA 120
492 RESPIRATION ABNORMAL 120
493 PREMATURE BABY 119
494 BURSITIS 118
495 PRODUCT DISPENSING ERROR 118
496 RESTLESSNESS 118
497 SARCOIDOSIS 118
498 BLOOD PRESSURE DIASTOLIC INCREASED 117
499 BRONCHIAL OBSTRUCTION 117
500 DEAFNESS 116
501 JOINT DISLOCATION 116
502 PULMONARY PAIN 116
503 PULMONARY THROMBOSIS 116
504 CROHN^S DISEASE 115
505 EATING DISORDER 115
506 MASTOCYTOSIS 115
507 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 114
508 HAEMATURIA 114
509 SKIN HAEMORRHAGE 114
510 PIGMENTATION DISORDER 113
511 PRODUCT ADMINISTRATION ERROR 113
512 ARTHROPOD BITE 111
513 CANDIDA INFECTION 111
514 GOUT 111
515 PERIORBITAL SWELLING 111
516 ANKLE FRACTURE 110
517 HIATUS HERNIA 110
518 PYELONEPHRITIS 110
519 RESPIRATORY SYNCYTIAL VIRUS INFECTION 110
520 WOUND SECRETION 110
521 GASTRIC DISORDER 109
522 INTESTINAL OBSTRUCTION 109
523 PEAK EXPIRATORY FLOW RATE DECREASED 109
524 ALLERGIC GRANULOMATOUS ANGIITIS 108
525 CHOKING SENSATION 108
526 FEAR OF INJECTION 108
527 MEDICATION ERROR 108
528 ANIMAL SCRATCH 107
529 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 107
530 IMPAIRED HEALING 107
531 IMPAIRED QUALITY OF LIFE 107
532 INJECTION SITE MASS 107
533 IRRITABLE BOWEL SYNDROME 107
534 NEUTROPHIL COUNT INCREASED 107
535 TERMINAL INSOMNIA 107
536 URTICARIA CHRONIC 107
537 FACIAL PAIN 106
538 SPUTUM CULTURE POSITIVE 106
539 INJECTION SITE WARMTH 105
540 SURGERY 105
541 DRUG DELIVERY SYSTEM MALFUNCTION 104
542 NERVOUS SYSTEM DISORDER 104
543 WEIGHT FLUCTUATION 104
544 DEVICE LEAKAGE 103
545 FLATULENCE 103
546 PRODUCT SUPPLY ISSUE 103
547 TOOTHACHE 103
548 NERVE COMPRESSION 102
549 PRODUCT DOSE OMISSION IN ERROR 102
550 SINUS HEADACHE 102
551 SWELLING OF EYELID 102
552 CYSTIC FIBROSIS 101
553 EXPIRED PRODUCT ADMINISTERED 101
554 IMMUNOSUPPRESSION 101
555 RESPIRATORY RATE DECREASED 101
556 POLYP 100
557 SPINAL FRACTURE 100
558 CYST 99
559 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 99
560 THROMBOCYTOPENIA 99
561 CYANOSIS 98
562 LOWER LIMB FRACTURE 98
563 LYMPHOMA 98
564 MOOD ALTERED 98
565 PARALYSIS 98
566 SPUTUM INCREASED 98
567 TOTAL LUNG CAPACITY INCREASED 98
568 MOOD SWINGS 97
569 PHARYNGEAL DISORDER 97
570 PSEUDOMONAS INFECTION 97
571 SCAB 97
572 HYPOGLYCAEMIA 96
573 LIGAMENT RUPTURE 96
574 PLEURITIC PAIN 96
575 POLYMYALGIA RHEUMATICA 96
576 SPIROMETRY ABNORMAL 96
577 THERAPEUTIC RESPONSE UNEXPECTED 96
578 URTICARIA THERMAL 96
579 EMOTIONAL DISORDER 95
580 MECHANICAL URTICARIA 95
581 RASH GENERALISED 95
582 AGGRESSION 94
583 ASPERGILLUS INFECTION 94
584 CARDIOMEGALY 94
585 GENERALISED OEDEMA 94
586 CARDIAC MURMUR 93
587 DISEASE PROGRESSION 93
588 HIP FRACTURE 93
589 LIVER DISORDER 93
590 PREMATURE DELIVERY 93
591 DEVICE USE ERROR 92
592 EYE INFLAMMATION 92
593 HALLUCINATION 92
594 PROSTATE CANCER 92
595 RESPIRATORY ARREST 92
596 DIZZINESS POSTURAL 91
597 HYPOPHAGIA 91
598 ORAL DISCOMFORT 91
599 BREAST PAIN 90
600 INCORRECT ROUTE OF DRUG ADMINISTRATION 90
601 NASAL DISORDER 90
602 SNORING 90
603 THERAPY CESSATION 90
604 BLADDER PAIN 89
605 DECREASED IMMUNE RESPONSIVENESS 89
606 FOOD INTOLERANCE 89
607 SCIATICA 89
608 THERMAL BURN 89
609 CARPAL TUNNEL SYNDROME 88
610 FEEDING DISORDER 88
611 PLATELET COUNT DECREASED 88
612 WHITE BLOOD CELL COUNT DECREASED 88
613 WOUND COMPLICATION 88
614 FRACTURE 87
615 MUSCLE TWITCHING 87
616 TACHYPNOEA 87
617 URINARY INCONTINENCE 87
618 EAR SWELLING 86
619 OSTEOPENIA 86
620 SKIN SWELLING 86
621 SUSPECTED OFF LABEL USE 86
622 VIRAL UPPER RESPIRATORY TRACT INFECTION 86
623 VITAMIN D DEFICIENCY 86
624 BONE DISORDER 85
625 ORAL PRURITUS 85
626 SKIN CANCER 85
627 VAGINAL HAEMORRHAGE 85
628 AGEUSIA 84
629 DIPLOPIA 84
630 FACIAL PARALYSIS 84
631 FOOD POISONING 84
632 LUNG HYPERINFLATION 84
633 HAND FRACTURE 83
634 MULTIPLE SCLEROSIS 83
635 ACUTE RESPIRATORY FAILURE 82
636 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 82
637 PNEUMOTHORAX 82
638 SENSITIVE SKIN 82
639 WOUND INFECTION 82
640 ACCIDENTAL UNDERDOSE 81
641 EPILEPSY 81
642 MUSCLE DISORDER 81
643 PERICARDITIS 81
644 SENSORY DISTURBANCE 81
645 TUNNEL VISION 81
646 UPPER RESPIRATORY TRACT CONGESTION 81
647 ALLERGY TO CHEMICALS 80
648 BLOOD GLUCOSE ABNORMAL 80
649 BREAST MASS 80
650 COGNITIVE DISORDER 80
651 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 80
652 NASAL PRURITUS 80
653 NIGHTMARE 80
654 RECTAL HAEMORRHAGE 80
655 EXPOSURE TO ALLERGEN 79
656 RASH PAPULAR 79
657 COLITIS 78
658 PHARYNGEAL PARAESTHESIA 78
659 PRODUCT PREPARATION ERROR 78
660 SPINAL PAIN 78
661 STOMATITIS 78
662 URINARY TRACT DISCOMFORT 78
663 COLITIS ULCERATIVE 77
664 COMA 77
665 GENERAL PHYSICAL CONDITION ABNORMAL 77
666 GLOSSODYNIA 77
667 ROTATOR CUFF SYNDROME 77
668 ABDOMINAL PAIN LOWER 76
669 CONJUNCTIVITIS ALLERGIC 76
670 DISORIENTATION 76
671 EYE INFECTION 76
672 FLANK PAIN 76
673 OVERWEIGHT 76
674 PHOTOPHOBIA 76
675 PRODUCT DOSE OMISSION 76
676 BRONCHIAL WALL THICKENING 75
677 HEART RATE ABNORMAL 75
678 INJECTION RELATED REACTION 75
679 PNEUMONIA BACTERIAL 75
680 SKIN ULCER 75
681 TONGUE OEDEMA 75
682 BACK DISORDER 74
683 HEPATIC STEATOSIS 74
684 NASAL DISCOMFORT 74
685 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 74
686 RESPIRATORY SYMPTOM 74
687 TENDERNESS 74
688 ORAL PAIN 73
689 ALANINE AMINOTRANSFERASE INCREASED 72
690 ALVEOLAR OSTEITIS 72
691 BODY TEMPERATURE ABNORMAL 72
692 FEV1/FVC RATIO DECREASED 72
693 STREPTOCOCCAL INFECTION 72
694 PAIN IN JAW 71
695 PARKINSON^S DISEASE 71
696 CARDIOVASCULAR DISORDER 70
697 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 70
698 INTERSTITIAL LUNG DISEASE 70
699 LUNG DIFFUSION TEST DECREASED 70
700 MENSTRUATION IRREGULAR 70
701 MUSCLE STRAIN 70
702 OTORRHOEA 70
703 BRONCHIAL DISORDER 69
704 DERMATITIS ALLERGIC 69
705 EYELID OEDEMA 69
706 MOUTH ULCERATION 69
707 ACUTE MYOCARDIAL INFARCTION 68
708 CONVULSION 68
709 MALIGNANT MELANOMA 68
710 POST PROCEDURAL INFECTION 68
711 PULMONARY HYPERTENSION 68
712 SCAR 68
713 THIRST 68
714 UMBILICAL HERNIA 68
715 ATELECTASIS 67
716 CLAUSTROPHOBIA 67
717 COELIAC DISEASE 67
718 DEVICE DIFFICULT TO USE 67
719 EYE DISCHARGE 67
720 PERIPHERAL COLDNESS 67
721 RED BLOOD CELL COUNT DECREASED 67
722 SKIN MASS 67
723 BLOOD IMMUNOGLOBULIN E DECREASED 66
724 PERICARDIAL EFFUSION 66
725 ULCER 66
726 EOSINOPHIL COUNT ABNORMAL 65
727 NODULE 65
728 RETCHING 65
729 URTICARIAL VASCULITIS 65
730 APHASIA 64
731 DRUG RESISTANCE 64
732 OVARIAN CYST 64
733 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 64
734 PSORIATIC ARTHROPATHY 64
735 TONGUE DISORDER 64
736 FORCED EXPIRATORY FLOW DECREASED 63
737 HAEMORRHOIDS 63
738 HYPERTHYROIDISM 63
739 RED BLOOD CELL COUNT INCREASED 63
740 RED BLOOD CELL SEDIMENTATION RATE INCREASED 63
741 RESPIRATORY TRACT INFLAMMATION 63
742 STATUS ASTHMATICUS 63
743 STEROID DIABETES 63
744 UTERINE LEIOMYOMA 63
745 ABASIA 62
746 ADVERSE REACTION 62
747 DIABETES MELLITUS INADEQUATE CONTROL 62
748 GASTROINTESTINAL HAEMORRHAGE 62
749 NASAL OBSTRUCTION 62
750 NASAL SEPTUM DEVIATION 62
751 SUICIDE ATTEMPT 62
752 TUBERCULOSIS 62
753 EXTRA DOSE ADMINISTERED 61
754 SENSORY LOSS 61
755 ARTHROPOD STING 60
756 COLD URTICARIA 60
757 COLON CANCER 60
758 DRUG EFFECT LESS THAN EXPECTED 60
759 FEELING JITTERY 60
760 IMPAIRED GASTRIC EMPTYING 60
761 INCREASED VISCOSITY OF BRONCHIAL SECRETION 60
762 INFUSION RELATED REACTION 60
763 INJECTION SITE HAEMATOMA 60
764 INJECTION SITE SCAB 60
765 LIP OEDEMA 60
766 MITE ALLERGY 60
767 OCULAR DISCOMFORT 60
768 REBOUND EFFECT 60
769 NONSPECIFIC REACTION 59
770 PANIC REACTION 59
771 RED CELL DISTRIBUTION WIDTH INCREASED 59
772 SKIN ABRASION 59
773 ANEURYSM 58
774 BLOOD CREATINE PHOSPHOKINASE INCREASED 58
775 EAR DISORDER 58
776 EYE HAEMORRHAGE 58
777 FACTOR V LEIDEN MUTATION 58
778 GLUCOSE TOLERANCE IMPAIRED 58
779 HYPOSMIA 58
780 INSURANCE ISSUE 58
781 PETECHIAE 58
782 POSTOPERATIVE WOUND INFECTION 58
783 PRODUCT TEMPERATURE EXCURSION ISSUE 58
784 RESTLESS LEGS SYNDROME 58
785 ABSCESS 57
786 ADVERSE EVENT 57
787 ANGER 57
788 ASPARTATE AMINOTRANSFERASE INCREASED 57
789 BRADYCARDIA 57
790 GASTRIC ULCER 57
791 LARYNGOSPASM 57
792 LIPOMA 57
793 LOCAL SWELLING 57
794 PERIORBITAL OEDEMA 57
795 ROSACEA 57
796 SHOCK 57
797 TONSILLITIS 57
798 TYPE I HYPERSENSITIVITY 57
799 APPENDICITIS 56
800 BODY HEIGHT DECREASED 56
801 DEMENTIA 56
802 FAECES DISCOLOURED 56
803 HYPOPNOEA 56
804 LABYRINTHITIS 56
805 LEUKOCYTOSIS 56
806 PAROSMIA 56
807 PRODUCT DISTRIBUTION ISSUE 56
808 HAEMATOCRIT DECREASED 55
809 INJECTION SITE IRRITATION 55
810 INTRACRANIAL PRESSURE INCREASED 55
811 SKIN SENSITISATION 55
812 SUNBURN 55
813 CARDIOMYOPATHY 54
814 DIAPHRAGMATIC DISORDER 54
815 HUNGER 54
816 HYPERAESTHESIA 54
817 HYPOGAMMAGLOBULINAEMIA 54
818 PAINFUL RESPIRATION 54
819 PHLEBITIS 54
820 SPINAL DISORDER 54
821 ANIMAL BITE 53
822 GASTROINTESTINAL INFECTION 53
823 HYPERCHOLESTEROLAEMIA 53
824 MYCOTIC ALLERGY 53
825 OTITIS MEDIA 53
826 CLAVICLE FRACTURE 52
827 EYE OEDEMA 52
828 INCREASED APPETITE 52
829 MUSCLE ATROPHY 52
830 SKIN ATROPHY 52
831 VARICOSE VEIN 52
832 APHTHOUS ULCER 51
833 APPARENT DEATH 51
834 BELL^S PALSY 51
835 BRONCHIOLITIS 51
836 DRUG ADMINISTRATION ERROR 51
837 LEFT VENTRICULAR HYPERTROPHY 51
838 MYASTHENIA GRAVIS 51
839 PNEUMONIA ASPIRATION 51
840 SEDATION 51
841 SLUGGISHNESS 51
842 SUFFOCATION FEELING 51
843 TENDON RUPTURE 51
844 TOOTH FRACTURE 51
845 CHRONIC KIDNEY DISEASE 50
846 FORMICATION 50
847 HAEMATEMESIS 50
848 HEPATIC CIRRHOSIS 50
849 INFUSION SITE PAIN 50
850 LEUKAEMIA 50
851 LUNG INFILTRATION 50
852 PLEURISY 50
853 TRYPTASE INCREASED 50
854 URINARY RETENTION 50
855 ACQUIRED FACTOR V DEFICIENCY 49
856 AORTIC ANEURYSM 49
857 AUTOIMMUNE THYROIDITIS 49
858 BLOOD PRESSURE SYSTOLIC DECREASED 49
859 COAGULATION FACTOR DEFICIENCY 49
860 EOSINOPHILIC OESOPHAGITIS 49
861 GALLBLADDER DISORDER 49
862 HYPERTENSIVE CRISIS 49
863 NEOPLASM 49
864 SENSE OF OPPRESSION 49
865 SPINAL CORD COMPRESSION 49
866 BRUXISM 48
867 PRODUCT PRESCRIBING ISSUE 48
868 STRIDOR 48
869 TREATMENT NONCOMPLIANCE 48
870 BLOOD SODIUM DECREASED 47
871 DYSKINESIA 47
872 ECCHYMOSIS 47
873 EYE ALLERGY 47
874 INCORRECT PRODUCT STORAGE 47
875 INJECTION SITE DISCOLOURATION 47
876 INJECTION SITE HYPERSENSITIVITY 47
877 NASAL DRYNESS 47
878 OSTEONECROSIS 47
879 RESPIRATORY TRACT INFECTION VIRAL 47
880 ALLERGY TO PLANTS 46
881 ARTERIAL OCCLUSIVE DISEASE 46
882 ATTENTION DEFICIT HYPERACTIVITY DISORDER 46
883 BASAL CELL CARCINOMA 46
884 BRONCHOPULMONARY ASPERGILLOSIS 46
885 CARDIO-RESPIRATORY ARREST 46
886 GESTATIONAL DIABETES 46
887 MACULAR DEGENERATION 46
888 OPTIC NEURITIS 46
889 OSTEOMYELITIS 46
890 BENIGN PROSTATIC HYPERPLASIA 45
891 BLOOD IMMUNOGLOBULIN G DECREASED 45
892 FEELING OF DESPAIR 45
893 HYPERLIPIDAEMIA 45
894 HYPERTHERMIA 45
895 JAUNDICE 45
896 NASAL INFLAMMATION 45
897 SKIN WARM 45
898 SPUTUM RETENTION 45
899 CORONARY ARTERY DISEASE 44
900 FEELING OF BODY TEMPERATURE CHANGE 44
901 FURUNCLE 44
902 GRIP STRENGTH DECREASED 44
903 HEPATITIS 44
904 LYMPHOCYTE COUNT DECREASED 44
905 OBSTRUCTIVE SLEEP APNOEA SYNDROME 44
906 PNEUMONIA FUNGAL 44
907 RASH VESICULAR 44
908 SKIN FISSURES 44
909 APPLICATION SITE PAIN 43
910 BACTERIAL DISEASE CARRIER 43
911 BLADDER DISORDER 43
912 BLOOD TRIGLYCERIDES INCREASED 43
913 BODY MASS INDEX INCREASED 43
914 BRONCHIAL HYPERREACTIVITY 43
915 CEREBRAL HAEMORRHAGE 43
916 DEPRESSED LEVEL OF CONSCIOUSNESS 43
917 HEMIPARESIS 43
918 INJECTION SITE INDURATION 43
919 INJECTION SITE INFLAMMATION 43
920 LIQUID PRODUCT PHYSICAL ISSUE 43
921 LOCALISED OEDEMA 43
922 MENSTRUAL DISORDER 43
923 MICTURITION URGENCY 43
924 MYOCARDITIS 43
925 ORTHOSTATIC HYPOTENSION 43
926 PRODUCT STORAGE ISSUE 43
927 RASH PUSTULAR 43
928 RENAL PAIN 43
929 SINUS POLYP 43
930 ABDOMINAL HERNIA 42
931 CORONARY ARTERY OCCLUSION 42
932 DYSPHEMIA 42
933 INFECTIOUS MONONUCLEOSIS 42
934 INJECTION SITE HYPOAESTHESIA 42
935 KNEE ARTHROPLASTY 42
936 OBSTRUCTION 42
937 PARANASAL SINUS HYPERSECRETION 42
938 PERIARTHRITIS 42
939 SEPTIC SHOCK 42
940 SERUM FERRITIN DECREASED 42
941 TASTE DISORDER 42
942 THYROID CANCER 42
943 VACCINATION SITE PAIN 42
944 CUSHINGOID 41
945 FEMUR FRACTURE 41
946 FOOT DEFORMITY 41
947 GASTROINTESTINAL PAIN 41
948 MIDDLE EAR EFFUSION 41
949 NOCTURNAL DYSPNOEA 41
950 POST-TRAUMATIC STRESS DISORDER 41
951 PRODUCT PACKAGING ISSUE 41
952 SALIVARY HYPERSECRETION 41
953 VITAMIN B12 DEFICIENCY 41
954 VOCAL CORD DISORDER 41
955 COAGULATION FACTOR V LEVEL ABNORMAL 40
956 DEVICE FAILURE 40
957 ENDOMETRIOSIS 40
958 ERECTILE DYSFUNCTION 40
959 EYELID PTOSIS 40
960 INFUSION SITE ERYTHEMA 40
961 RETINAL DETACHMENT 40
962 SINUS TACHYCARDIA 40
963 CATARRH 39
964 CRYOPYRIN ASSOCIATED PERIODIC SYNDROME 39
965 DYSMENORRHOEA 39
966 EXOSTOSIS 39
967 EXPOSURE TO SARS-COV-2 39
968 FOREIGN BODY SENSATION IN EYES 39
969 PEMPHIGOID 39
970 TENDON PAIN 39
971 TYPE 1 DIABETES MELLITUS 39
972 ANKYLOSING SPONDYLITIS 38
973 BEDRIDDEN 38
974 BLOOD DISORDER 38
975 BRAIN NEOPLASM 38
976 CUSHING^S SYNDROME 38
977 DEVICE BREAKAGE 38
978 FOLLICULITIS 38
979 JOINT RANGE OF MOTION DECREASED 38
980 PANCREATIC CARCINOMA 38
981 SKIN HYPERTROPHY 38
982 THYROID MASS 38
983 TONGUE DISCOLOURATION 38
984 TOXIC EPIDERMAL NECROLYSIS 38
985 URTICARIA PRESSURE 38
986 VERTIGO POSITIONAL 38
987 ACUTE KIDNEY INJURY 37
988 ACUTE SINUSITIS 37
989 ADDISON^S DISEASE 37
990 AMENORRHOEA 37
991 BLOOD IMMUNOGLOBULIN E ABNORMAL 37
992 BONE DENSITY DECREASED 37
993 CHROMATURIA 37
994 HELICOBACTER INFECTION 37
995 INFECTION SUSCEPTIBILITY INCREASED 37
996 NAIL DISCOLOURATION 37
997 OESOPHAGITIS 37
998 PRODUCT CONTAINER ISSUE 37
999 SCOLIOSIS 37